Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

MarketScreener Homepage  >  Equities  >  Nyse  >  UnitedHealth Group    UNH


SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

UnitedHealth Group : Updates Business Outlook Ahead of Investor Conference

12/01/2020 | 06:32am EST

UnitedHealth Group (NYSE: UNH) issued an updated 2020 outlook and its initial view of 2021 ahead of its annual Investor Conference with analysts and institutional investors taking place virtually today, beginning at 9:00 a.m. ET.

Under the updated outlook, UnitedHealth Group revenues for 2020 are expected to approximate $257 billion, with net earnings to approach $15.90 per share and adjusted net earnings to approach $16.75 per share. Adjusted net earnings exclude from net earnings only the after-tax non-cash amortization expense pertaining to acquisition-related intangible assets.

UnitedHealth Group will also introduce its initial 2021 outlook, which includes revenues of $277 billion to $280 billion, net earnings of $16.90 to $17.40 per share, and adjusted net earnings of $17.75 to $18.25 per share. These figures include approximately $1.80 per share in potential net unfavorable impact to accommodate continuing COVID-19 effects, such as: treatment and testing costs; the residual impact of people deferring care in 2020; and unemployment and other economic-driven factors. Cash flows from operations are expected to range from $20 billion to $21 billion in 2021.

The Company will stream the presentation and management question-and-answer portion of this meeting on its Investor Relations page at www.unitedhealthgroup.com. Meeting materials, including financial metrics for 2020 and the initial outlook for 2021, will also be available on the Investor Relations page. A replay of the conference will be available on the Company web site.

About UnitedHealth Group

UnitedHealth Group (NYSE: UNH) is a diversified health care company dedicated to helping people live healthier lives and helping make the health system work better for everyone. UnitedHealth Group offers a broad spectrum of products and services through two distinct platforms: UnitedHealthcare, which provides health care coverage and benefits services; and Optum, which provides information and technology-enabled health services. For more information, visit UnitedHealth Group at www.unitedhealthgroup.com or follow @UnitedHealthGrp on Twitter.

Non-GAAP Financial Information

This news release presents non-GAAP financial information provided as a complement to the results provided in accordance with accounting principles generally accepted in the United States of America (“GAAP”). Adjusted net earnings exclude amortization expense of approximately $1.10 per share and the related tax impact of $0.25 per share for both years ending December 31, 2020 and 2021, pertaining to acquisition-related intangible assets.

Forward-Looking Statements

The statements, estimates, projections, guidance or outlook contained in this document include “forward-looking” statements which are intended to take advantage of the “safe harbor” provisions of the federal securities law. The words “believe,” “expect,” “intend,” “estimate,” “anticipate,” “forecast,” “outlook,” “plan,” “project,” “should” and similar expressions identify forward-looking statements. These statements may contain information about financial prospects, economic conditions and trends and involve risks and uncertainties. Actual results could differ materially from those that management expects, depending on the outcome of certain factors including: risks associated with public health crises, large-scale medical emergencies and pandemics, such as the COVID-19 pandemic; our ability to effectively estimate, price for and manage medical costs; new or changes in existing health care laws or regulations, or their enforcement or application; the DOJ’s legal action relating to the risk adjustment submission matter; our ability to maintain and achieve improvement in quality scores impacting revenue; reductions in revenue or delays to cash flows received under government programs; changes in Medicare, the CMS star ratings program or the application of risk adjustment data validation audits; failure to maintain effective and efficient information systems or if our technology products do not operate as intended; cyberattacks, other privacy/data security incidents, or our failure to comply with related regulations; risks and uncertainties associated with the pharmacy benefits management industry; competitive pressures; changes in or challenges to our public sector contract awards; our ability to contract on competitive terms with physicians, hospitals and other service providers; failure to achieve targeted operating cost productivity improvements; increases in costs and other liabilities associated with litigation, government investigations, audits or reviews; failure to manage successfully our strategic alliances or complete or receive anticipated benefits of strategic transactions; fluctuations in foreign currency exchange rates; downgrades in our credit ratings; our investment portfolio performance; impairment of our goodwill and intangible assets; and our ability to obtain sufficient funds from our regulated subsidiaries or from external financings to fund our obligations, maintain our debt to total capital ratio at targeted levels, maintain our quarterly dividend payment cycle, or continue repurchasing shares of our common stock. This above list is not exhaustive. We discuss these matters, and certain risks that may affect our business operations, financial condition and results of operations more fully in our filings with the SEC, including our reports on Forms 10-K, 10-Q and 8-K. By their nature, forward-looking statements are not guarantees of future performance or results and are subject to risks, uncertainties and assumptions that are difficult to predict or quantify. Actual results may vary materially from expectations expressed or implied in this document or any of our prior communications. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. We do not undertake to update or revise any forward-looking statements, except as required by law.

© Business Wire 2020
01/20Wall Street closes at record highs as Netflix jumps, Biden inaugurated
01/20WALL STREET STOCK EXCHANGE : Stocks Hit Records on Upbeat Earnings
01/20Health Ticks Higher After UnitedHealth Earnings - Health Care Roundup
01/20WALL STREET STOCK EXCHANGE : Stocks Climb to Records on Big Earnings Day
01/20SECTOR UPDATE : Health Care Stocks Put Up Moderate Advance This Afternoon
01/20SECTOR UPDATE : Health Care Stocks Posting Moderate Advance
01/20WALL STREET STOCK EXCHANGE : Stocks Extend Climb Amid Big Earnings Day
01/20UNITEDHEALTH : Profit Slips as Health-Care Visits Return--Update
01/20UNITEDHEALTH : overcomes pandemic hit and tops 4Q expectations
01/20GLOBAL MARKETS LIVE: Jack Ma reappears, Better-than-expected profits for Morg..
More news
Financials (USD)
Sales 2020 257 B - -
Net income 2020 15 357 M - -
Net Debt 2020 24 535 M - -
P/E ratio 2020 21,9x
Yield 2020 1,34%
Capitalization 333 B 333 B -
EV / Sales 2020 1,39x
EV / Sales 2021 1,25x
Nbr of Employees 325 000
Free-Float 99,4%
Duration : Period :
UnitedHealth Group Technical Analysis Chart | UNH | US91324P1021 | MarketScreener
Technical analysis trends UNITEDHEALTH GROUP
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus BUY
Number of Analysts 26
Average target price 395,57 $
Last Close Price 350,84 $
Spread / Highest target 31,7%
Spread / Average Target 12,7%
Spread / Lowest Target -6,23%
EPS Revisions
Managers and Directors
David Scott Wichmann Chief Executive Officer & Director
Andrew Philip Witty Group President
Stephen J. Hemsley Chairman
John Franklin Rex Chief Financial Officer & Executive Vice President
Richard J. Migliori Chief Medical Officer & EVP-Medical Affairs
Sector and Competitors
1st jan.Capitalization (M$)
ANTHEM, INC.0.13%79 963
HUMANA INC.-0.72%54 437